Clinical Trial Update: Efficacy of Pulmozyme® on Arterial Recanalization in Post-thrombectomy Patients Managed for Ischemic Stroke (NETs-target) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether Pulmozyme (dornase alfa) improves arterial recanalization in ischemic stroke patients after thrombectomy; trial comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Pulmozyme (dornase alfa)

Snippet

Sponsor: Fondation Ophtalmologique Adolphe de Rothschild | Conditions: Ischemic Stroke | Phase 2 | Status: COMPLETED